What is ACRV's dilution risk score?

ACRV has a latest available DilutionScore record of 37/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ACRV, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ACRV?

DilutionWatch tracks 25 SEC filing types for ACRV including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ACRV shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ACRV, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ACRV tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ACRV. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ACRV Dilution Risk Score: 37/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

40

📊 Float Risk

10

⚠️ Warrant Exposure

40

🔄Convertible Debt—

Dilution Forecast

☀️

Clear

No significant dilution signals

0%

No significant dilution signals detected for ACRV.

🔔 Track ACRV — Get forecast alerts →

Market Data

Market CapN/A

Shares Outstanding42.85M

Float16.87M

Cash$89.96M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↓ 0.3% shares (2026Q1 vs prior)

45 institutional holders · 17.57M shares

#1 RA CAPITAL MANAGEMENT, L.P. 8.34M shares

#2 Sands Capital Alternatives, LLC 2.12M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 1.44M shares

+ 17 more holders Sign up free to view →

Short Interest

Short Interest1.36M

Days to Cover4.3

% of Float8.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

Form 4 INSIDER TRANSACTION 2026-08-04

Form 4 INSIDER TRANSACTION 2026-07-21

4 INSIDER TRANSACTION 2026-06-22

Full SEC filing analysis available with free account →

Recent News

Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 20 GlobeNewswire · Aug 12

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, int GlobeNewswire · Aug 05

Factual ACRV Dilution Snapshot

Acrivon Therapeutics, Inc. (ACRV) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: August 14, 2026.

Recent SEC activity tracked for ACRV: Form 4 on 2026-08-04; Form 4 on 2026-07-21; 4 on 2026-06-22.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for ACRV

ACRV FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

ACRV — Acrivon Therapeutics, Inc. Dilution Risk Tracker